Mayne Pharma

Mayne Pharma is a specialty pharmaceutical company based in South Australia, listed on the Australian Securities Exchange (ASX). With a history that began in 1983, the company has developed a strong reputation for innovation in oral drug delivery systems. It has successfully commercialized a variety of products, including delayed-release doxycycline capsules (DORYX), enteric-coated aspirin (ASTRIX), and sustained-release morphine (KADIAN/KAPANOL). The company offers a range of services through its divisions, including contract development and manufacturing, specialty and generic product distribution, and international partnerships to enhance global access to its medications. Mayne Pharma employs over 400 staff worldwide and is recognized for its expertise in complex oral and topical dose forms. Its commitment to providing accessible and affordable medications supports patients globally.